Published in AIDS Weekly, July 27th, 1998
A Japanese study suggests that the intranasal route of vaccine administration may offer superior efficacy in such a vaccine ("Induction of Systemic and Mucosal Immune Responses to HIV-1 by a DNA Vaccine Formulated with QS-21 Saponin Adjuvant Via Intramuscular and Intranasal Routes," Journal of Virology, June 1998;72(6):4931-4939).
Induction of mucosal and cell-mediated immunity is critical for development of an effective vaccine against HIV.
In this study, S. Sasaki and colleagues compared intramuscular and intranasal immunizations...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
Source: AIDS Weekly (1998-07-27)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.